Richard Pye | VP, Corporate Affairs |
Glyn Edwards | CEO |
Melissa Strange | VP, Finance |
Hartaj Singh | Oppenheimer & Company |
Tim Chiang | BTIG |
Joseph Hedden | Rx Securities |
Yun Zhong | Janney |
Gary Waanders | Bryan Garnier |
Julie Simmonds | Panmure Gordon |
Dewey Steadman | Canaccord |
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to today's Summit Therapeutics Fourth Quarter and Fiscal Year Ending January 31 2019 Conference Call. At this time all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session.